First NHS treatment for an inherited retinal dystrophy - Retina UK speaks to three recipients

from Retina UK · host Retina UK

Retina UK Research Development Manager Kate Arkell speaks to three of the first people to receive the Luxturna (voretigene neparvovec) treatment in the UK. Jake, Lee and Matt all received the Luxturna gene therapy at the start of 2020. They all have two faulty copies of the RPE65 gene and are living with Leber congenital amaurosis type 2 (LCA2) and severe early-onset RP.

Episode metadata supplied by the publisher feed · Published Nov 30, 2020

Embed this episode

Attribution link and audio player

NOW PLAYING

First NHS treatment for an inherited retinal dystrophy - Retina UK speaks to three recipients

0:00 33:24

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Retina UK?

This episode is 33 minutes long.

When was this Retina UK episode published?

This episode was published on November 30, 2020.

Can I download this Retina UK episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!